Business · 22/03/2000Updated: 10/17/2026 · 1 min read
FDA's Orally Inhaled and Nasal Drug Products Subcommittee to Hold Meeting
Summary
The FDA's Orally Inhaled and Nasal Drug Products Subcommittee of the Advisory Committee for Pharmaceutical Science will hold a meeting, as announced in a notice on the FDA's website.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →